Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'OXYBUTYNIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 206 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lose, G; Norgaard, JP
      Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor

      BJU INTERNATIONAL
    2. Ferrara, P; D'Aleo, CM; Tarquini, E; Salvatore, S; Salvaggio, E
      Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida

      BJU INTERNATIONAL
    3. Hjalmas, K; Hellstrom, AL; Mogren, K; Lackgren, G; Stenberg, A
      The overactive bladder in children: a potential future indication for tolterodine

      BJU INTERNATIONAL
    4. Weatherall, M
      Managing urinary incontinence in the elderly

      HOSPITAL MEDICINE
    5. Jamil, F
      Towards a catheter free status in neurogenic bladder dysfunction: a reviewof bladder management options in spinal cord injury (SCI)

      SPINAL CORD
    6. Wein, AJ
      Pharmacological agents for the treatment of urinary incontinence due to overactive bladder

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    7. Ulshofer, B; Bihr, AM; Bodeker, RH; Schwantes, U; Jahn, HP
      Randomised, double-blind, placebo-controlled study on the efficacy and tolerance of trospium chloride in patients with motor urge incontinence

      CLINICAL DRUG INVESTIGATION
    8. Abrams, P; Malone-Lee, J; Jacquetin, B; Wyndaele, JJ; Tammela, T; Jonas, U; Wein, A
      Twelve-month treatment of overactive bladder - Efficacy and tolerability of tolterodine

      DRUGS & AGING
    9. Clemett, D; Jarvis, B
      Tolterodine - A review of its use in the treatment of overactive bladder

      DRUGS & AGING
    10. Azam, U; Castleden, M; Turner, D
      Economics of lower urinary tract symptoms (LUTS) in older people

      DRUGS & AGING
    11. Lemack, GE
      Overactive bladder: Optimizing quality of care

      AMERICAN JOURNAL OF MANAGED CARE
    12. McGhan, WF
      Cost effectiveness and quality of life considerations in the treatment of patients with overactive bladder

      AMERICAN JOURNAL OF MANAGED CARE
    13. Kaneko, K; Fujinaga, S; Ohtomo, Y; Shimizu, T; Yamashiro, Y
      Combined pharmacotherapy for nocturnal enuresis

      PEDIATRIC NEPHROLOGY
    14. Oki, T; Yamada, S; Tohma, A; Kimura, R
      Muscarinic receptor binding characteristics in rat tissues after oral administration of oxybutynin and propiverine

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    15. Zobrist, RH; Schmid, B; Feick, A; Quan, DY; Sanders, SW
      Pharmacokinetics of the R- and S-enantiomers of oxybutynin and N-desethyloxybutynin following oral and transdermal administration of the racemate in healthy volunteers

      PHARMACEUTICAL RESEARCH
    16. Andersson, KE; Chapple, CR
      Oxybutynin and the overactive bladder

      WORLD JOURNAL OF UROLOGY
    17. Hofner, K; Oelke, M; Machtens, S; Grunewald, V
      Trospium chloride - an effective drug in the treatment of overactive bladder and detrusor hyperreflexia

      WORLD JOURNAL OF UROLOGY
    18. Appell, RA; Abrams, P; Drutz, HP; Van Kerrebroeck, PEVA; Millard, R; Wein, A
      Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine

      WORLD JOURNAL OF UROLOGY
    19. van Gool, JD; Dik, P; de Jong, TPVM
      Bladder-sphincter dysfunction in myelomeningocele

      EUROPEAN JOURNAL OF PEDIATRICS
    20. Olsson, B; Szamosi, J
      Multiple dose pharmacokinetics of a new once daily extended release tolterodine formulation versus immediate release tolterodine

      CLINICAL PHARMACOKINETICS
    21. Sathyan, G; Chancellor, MB; Gupta, SK
      Effect of OROS (R) controlled-release delivery on the pharmacokinetics andpharmacodynamics of oxybutynin chloride

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    22. Jacquetin, B; Wyndaele, JJ
      Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    23. Springate, JE
      Oxybutynin does not affect cyclosporin blood levels

      THERAPEUTIC DRUG MONITORING
    24. Diokno, A; Lee, P; Zorn, BH; Lenderking, WR; Grossman, MA; Bull, SA; Albrecht, D
      Factors associated with clinical assessment of overactive bladder and selection of treatment

      CLINICAL THERAPEUTICS
    25. Chancellor, MB; Appell, RA; Sathyan, G; Gupta, SK
      A comparison of the effects on saliva output of oxybutynin chloride and tolterodine tartrate

      CLINICAL THERAPEUTICS
    26. Appell, RA; Anderson, R; Diokno, AC; Dmochowski, R; Staskin, D
      Tolterodine once-daily in treatment of the overactive bladder

      UROLOGY
    27. Van Kerrebroeck, P
      Tolterodine once-daily in treatment of the overactive bladder - Reply

      UROLOGY
    28. Hohenfellner, M; Pannek, J; Botel, U; Dahms, S; Pfitzenmaier, J; Fichtner, J; Hutschenreiter, G; Thuroff, JW
      Sacral bladder denervation for treatment of detrusor hyperreflexia and autonomic dysreflexia

      UROLOGY
    29. Van Kerrebroeck, P; Kreder, K; Jonas, U; Zinner, N; Wein, AN
      Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder

      UROLOGY
    30. Butler, RJ
      Combination therapy for nocturnal enuresis

      SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
    31. Serel, TA; Perk, H; Koyuncuoglu, HR; Kosar, A; Celik, K; Deniz, N
      Acupuncture therapy in the management of persistent primary nocturnal enuresis - Preliminary results

      SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
    32. Churchill, BM; Abramson, RP; Wahl, EF
      Dysfunction of the lower urinary and distal gastrointestinal tracts in pediatric patients with known spinal cord problems

      PEDIATRIC CLINICS OF NORTH AMERICA
    33. Elliott, DS; Lightner, DJ; Blute, ML
      Medical management of overactive bladder

      MAYO CLINIC PROCEEDINGS
    34. Shimizu, I; Kawashima, K; Ishii, D; Oka, M
      Effects of AH-9700, (+)-pentazocine, DTG and oxybutynin on micturition in anesthetized rats with acetone-induced cystitis

      LIFE SCIENCES
    35. Eglen, RM
      Muscarinic receptors and gastrointestinal tract smooth muscle function

      LIFE SCIENCES
    36. Zimmern, P
      Editorial: Intravesical treatment of bladder dysfunction

      JOURNAL OF UROLOGY
    37. Woods, M; Carson, N; Norton, NW; Sheldon, JH; Argentieri, TM
      Efficacy of the beta 3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat

      JOURNAL OF UROLOGY
    38. Davila, GW; Daugherty, CA; Sanders, SW
      A short-term multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence

      JOURNAL OF UROLOGY
    39. Lapointe, SP; Wang, BY; Kennedy, WA; Shortliffe, LMD
      The effects of intravesical lidocaine on bladder dynamics of children withmyelomeningocele

      JOURNAL OF UROLOGY
    40. Oka, T; Nakano, K; Kirimoto, T; Matsuura, N
      Effects of antimuscarinic drugs on both urinary frequency and cognitive impairment in conscious, nonrestrained rats

      JAPANESE JOURNAL OF PHARMACOLOGY
    41. Shimizu, I; Kawashima, K; Ishii, D; Oku, S; Kohayakawa, H; Oka, M
      Pharmacological actions of AH-9700 on micturition reflex in anesthetized rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    42. Pahlman, I; d'Argy, R; Nilvebrant, L
      Tissue distribution of tolterodine, a muscarinic receptor antagonist, and transfer into fetus and milk in mice

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    43. Pahlman, I; Kankaanranta, S; Palmer, L
      Pharmacokinetics of tolterodine, a muscarinic receptor antagonist, in mouse, rat and dog - Interspecies relationship comparing with human pharmacokinetics

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    44. Schnelle, JF; Smith, RL
      Quality indicators for the management of urinary incontinence in vulnerable community-dwelling elders

      ANNALS OF INTERNAL MEDICINE
    45. Harvey, MA; Baker, K; Wells, GA
      Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: A meta-analysis

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    46. Malone-Lee, JG; Walsh, JB; Maugourd, MF
      Tolterodine: A safe and effective treatment for older patients with overactive bladder

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    47. Hochgesand, D; Pfeiffer, N
      Systemic anticholinergics - Rarely a contraindication in glaucoma patients

      AKTUELLE UROLOGIE
    48. Robinson, D; Khullar, V; Cardozo, L
      Pharmacological management of detrusor instability

      INTERNATIONAL UROGYNECOLOGY JOURNAL AND PELVIC FLOOR DYSFUNCTION
    49. Andersson, KE
      Drug therapy for urinary incontinence

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    50. Hoebeke, PB; Vande Walle, J
      The pharmacology of paediatric incontinence

      BJU INTERNATIONAL
    51. Rovner, ES; Wein, AJ
      Modern pharmacotherapy of urge urinary incontinence in the USA: tolterodine and oxybutynin

      BJU INTERNATIONAL
    52. Birns, J; Lukkari, E; Malone-Lee, JG
      A randomized controlled trial comparing the efficacy of controlled-releaseoxybutynin tablets (10 mg once daily) with conventional oxybutynin tablets(5 mg twice daily) in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin

      BJU INTERNATIONAL
    53. Cardozo, L; Chapple, CR; Toozs-Hobson, P; Grosse-Freese, M; Bulitta, M; Lehmacher, W; Strosser, W; Ballering-Bruhl, B; Schafer, M
      Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial

      BJU INTERNATIONAL
    54. Yoshimura, N; Smith, CP; Chancellor, MB; de Groat, WC
      Pharmacologic and potential biologic interventions to restore bladder function after spinal cord injury

      CURRENT OPINION IN NEUROLOGY
    55. Chancellor, M; Freedman, S; Mitcheson, HD; Antoci, J; Primus, G; Wein, A
      Tolterodine, an effective and well tolerated treatment for urge incontinence and other overactive bladder symptoms

      CLINICAL DRUG INVESTIGATION
    56. Abrams, P; Kelleher, CJ; Kerr, LA; Rogers, RG
      Overactive bladder significantly affects quality of life

      AMERICAN JOURNAL OF MANAGED CARE
    57. Ouslander, JG; Shih, YCT; Malone-Lee, J; Luber, K
      Overactive bladder: Special considerations in the geriatric population

      AMERICAN JOURNAL OF MANAGED CARE
    58. Couture, JA; Valiquette, L
      Urinary incontinence

      ANNALS OF PHARMACOTHERAPY
    59. Bulmer, P; Abrams, P
      The overactive bladder

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    60. Malone-Lee, JG
      The efficacy, tolerability and safety profile of tolterodine in the treatment of overactive/unstable bladder

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    61. Fusgen, I; Hauri, D
      Trospium chloride: an effective option for medical treatment of bladder overactivity

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    62. Kim, DY; Chancellor, MB
      Intravesical neuromodulatory drugs: Capsaicin and resiniferatoxin to treatthe overactive bladder

      JOURNAL OF ENDOUROLOGY
    63. Smith, DA; Ouslander, JG
      Pharmacologic management of urinary incontinence in older adults

      TOPICS IN GERIATRIC REHABILITATION
    64. Durand, A; Serment, G; Bladou, F
      Drug therapy for urinary incontinence

      PRESSE MEDICALE
    65. Saito, M; Tabuchi, F; Otsubo, K; Miyagawa, I
      Treatment of overactive bladder with modified intravesical oxybutynin chloride

      NEUROUROLOGY AND URODYNAMICS
    66. Sugaya, K; Nishizawa, O; Satoh, T; Hatano, T; Ogawa, Y
      Bladder-pumping therapy for the treatment of low-capacity or low-compliance bladders

      NEUROUROLOGY AND URODYNAMICS
    67. De Castro, R; Neel, KAF; Alshammari, AM; Abu Daia, JM; Al Abd Al-Aaly, M
      Clean intermittent catheterization in Saudi children - Suggestion for a common protocol

      SAUDI MEDICAL JOURNAL
    68. Sprem, M; Milicic, D; Oreskovic, S; Ljubojevic, N; Kalafatic, D
      Intravesically administered ketoprofen in treatment of detrusor instability: Cross-over study

      CROATIAN MEDICAL JOURNAL
    69. Homma, Y; Kondo, Y; Takahashi, S; Kitamura, T; Kawabe, K
      Reproducibility of cystometry in overactive detrusor

      EUROPEAN UROLOGY
    70. Dorschner, W; Stolzenburg, JU; Griebenow, R; Halaska, M; Schubert, G; Murtz, G; Frank, M; Wieners, F
      Efficacy and cardiac safety of propiverine in elderly patients - A double-blind, placebo-controlled clinical study

      EUROPEAN UROLOGY
    71. Bemelmans, BLH; Kiemeney, LALM; Debruyne, FMJ
      Low-dose oxybutynin for the treatment of urge incontinence: Good efficacy and few side effects

      EUROPEAN UROLOGY
    72. Jones, SE; Kasamaki, Y; Shuba, LM; Ogura, T; McCullough, JR; McDonald, TF
      Analysis of the electrophysiologic effects of short-term oxybutynin on guinea pig and rabbit ventricular cells

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    73. Dmochowski, RR; Appell, RA
      Advancements in pharmacologic management of the overactive bladder

      UROLOGY
    74. Schroder, A; Levin, RM; Kogan, BA; Das, AK; Kay, F; Mahashabde, A
      Absorption of oxybutynin from vaginal inserts: Drug blood levels and the response of the rabbit bladder

      UROLOGY
    75. Chapple, CR
      Muscarinic receptor antagonists in the treatment of overactive bladder

      UROLOGY
    76. Fowler, CJ
      Intravesical treatment of overactive bladder

      UROLOGY
    77. Goessl, C; Sauter, T; Michael, T; Berge, B; Staehler, M; Miller, K
      Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia

      UROLOGY
    78. Tahmaz, L; Kibar, Y; Yildirim, I; Ceylan, S; Dayanc, M
      Combination therapy of imipramine with oxybutynin in children with enuresis nocturna

      UROLOGIA INTERNATIONALIS
    79. Saito, M; Miyagawa, I
      Bladder dysfunction due to Behcet's disease

      UROLOGIA INTERNATIONALIS
    80. Kosar, A; Akkus, S; Savas, S; Ozturk, A; Serel, TA; Kecelioglu, M
      Effect of ultrasound in the treatment of primary nocturnal enuresis

      SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
    81. Butler, RJ; Holland, P
      The three systems: a conceptual way of understanding nocturnal enuresis

      SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
    82. Curran, MJ; Kaefer, M; Peters, C; Logigian, E; Bauer, SB
      The overactive bladder in childhood: Long-term results with conservative management

      JOURNAL OF UROLOGY
    83. Grover, PT; Bhongle, NN; Wald, SA; Senanayake, CH
      Chiral mandelic acid template provides a highly practical solution for (S)-oxybutynin synthesis

      JOURNAL OF ORGANIC CHEMISTRY
    84. Kamo, I; Imai, S; Okanishi, S; Doi, T
      Possible site of action of TAK-637, a tachykinin NK1 receptor antagonist, on the micturition reflex in guinea pigs

      EUROPEAN JOURNAL OF PHARMACOLOGY
    85. Schulman, SL; Colish, Y; von Zuben, FC; Kodman-Jones, C
      Effectiveness of treatments for nocturnal enuresis in a heterogeneous population

      CLINICAL PEDIATRICS
    86. Jones, SE; Shuba, LM; Zhabyeyev, P; McCullough, JR; McDonald, TF
      Differences in the effects of urinary incontinence agents S-oxybutynin andterodiline on cardiac K+ currents and action potentials

      BRITISH JOURNAL OF PHARMACOLOGY
    87. Uckert, S; Stief, CG; Odenthal, KP; Truss, MC; Lietz, B; Jonas, U
      Responses of isolated normal human detrusor muscle to various spasmolytic drugs commonly used in the treatment of the overactive bladder

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    88. Jonas, U; Hofner, K; Madersbacher, H; Holmdahl, TH; Freeman, R; Anderstrom, C; Mattiasson, A; Abrams, P
      Tolterodine - A new drug for the treatment of urge incontinence. Clinical and urodynamic efficacy and comparison with oxybutynin

      AKTUELLE UROLOGIE
    89. Niknejad, KG; Atala, A
      Bladder augmentation techniques in women

      INTERNATIONAL UROGYNECOLOGY JOURNAL AND PELVIC FLOOR DYSFUNCTION
    90. Andersson, KE; Appell, R; Cardozo, LD; Chapple, C; Drutz, HP; Finkbeiner, AE; Haab, F; Navarrete, RV
      The pharmacological treatment of urinary incontinence

      BJU INTERNATIONAL
    91. Madersbacher, H; Halaska, M; Voigt, R; Alloussi, S; Hofner, K
      A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence

      BJU INTERNATIONAL
    92. Abrams, P; Larsson, G; Chapple, C; Wein, AJ
      Factors involved in the success of antimuscarinic treatment

      BJU INTERNATIONAL
    93. Messelink, EJ
      Treatment of the overactive bladder with tolterodine, a new muscarinic receptor antagonist

      BJU INTERNATIONAL
    94. Massoud, R; Federici, G; Casciani, S; Di Stasi, SM; Fucci, G; Giannantoni, A; Cortese, C
      Extraction and determination of oxybutynin in human bladder samples by reversed-phase high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    95. Stohrer, M; Madersbacher, H; Richter, R; Wehnert, J; Dreikorn, K
      Efficacy and safety of propiverine in SCI-patients suffering from detrusorhyperreflexia - A double-blind, placebo-controlled clinical trial

      SPINAL CORD
    96. Ruscin, JM; Morgenstern, NE
      Tolterodine use for symptoms of overactive bladder

      ANNALS OF PHARMACOTHERAPY
    97. Sullivan, J; Abrams, P
      The overactive bladder: neuropharmacological basis of clinical management

      CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
    98. Miyachi, H; Kiyota, H; Uchiki, H; Segawa, M
      Synthesis and antimuscarinic activity of a series of 4-(1-imidazolyl)-2,2-diphenylbutyramides: Discovery of potent and subtype-selective antimuscarinic agents

      BIOORGANIC & MEDICINAL CHEMISTRY
    99. Miyachi, H; Kiyota, H; Segawa, M
      Design, synthesis and antimuscarinic activity of some imidazolium derivatives

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    100. Schwantes, U; Topfmeier, P
      Importance of pharmacological and physicochemical properties for toleranceof antimuscarinic drugs in the treatment of detrusor instability and detrusor hyperreflexia - Chances for improvement of therapy

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/02/20 alle ore 14:52:42